This is an X-PIL, which is a text only patient information leaflet, designed for people with sight problems.
Table of Contents
Alkeran® 50mg
Powder and Solvent for Solution for Infusion,
melphalan
1 What Alkeran is and what it is used for2 Before you have Alkeran3 How to have Alkeran4 Possible side effects5 How to store Alkeran6 Further information
Alkeran injection contains a medicine called melphalan. This belongs to a group of medicines called cytotoxics (also called chemotherapy). Alkeran is used to treat cancer. It works by reducing the number of abnormal cells your body makes.
Alkeran is used for:
Ask your doctor if you would like more explanation about these diseases.
Do not have Alkeran if the above applies to you. If you are not sure, talk to your doctor or nurse before having Alkeran.
Before you use Alkeran, tell your doctor or nurse if:
If you are not sure if any of the above apply to you, talk to your doctor or nurse before having Alkeran.
Please tell your doctor or nurse if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This includes herbal medicines.
In particular, tell your doctor or nurse if you are taking any of the following:
If you are going to have a vaccination speak to your doctor or nurse before you have it. This is because some vaccines (like polio, measles, mumps and rubella) may give you an infection if you have them whilst you are being treated with Alkeran.
Do not take Alkeran if you are planning to have a baby. This applies to both men and women.
Reliable contraceptive precautions must be taken to avoid pregnancy whilst you or your partner is having this injection. Ask your doctor for advice.
Treatment with Alkeran is not recommended during pregnancy because it may cause permanent damage to a foetus. If you are pregnant, if you think you could be pregnant, or if you are planning to become pregnant, check with your doctor before you take Alkeran. Your doctor will consider the risks and benefits to you and your baby of taking Alkeran.
Do not breast-feed during treatment with Alkeran. Ask your doctor or midwife for advice.
Alkeran should only be prescribed for you by a specialist doctor who is experienced in treating blood problems or cancer.
Alkeran injection can be given:
Your doctor will decide how much Alkeran you will have. The amount of Alkeran depends on:
When you are given Alkeran, your doctor will take regular blood tests. This is to check the number of cells in your blood. Your doctor may sometimes change your dose as a result of these tests.
Your doctor will give you Alkeran so it is unlikely that you will receive too much. If you think you have been given too much or have missed a dose, tell your doctor or nurse.
Like all medicines, Alkeran can cause side effects, although not everybody gets them.
Talk to your doctor if you have any of the following side effects, which may also happen with this medicine:
skin rashes or itching skin
If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
It is also possible that the use of Alkeran will increase the risk of developing another type of cancer called secondary acute leukaemia (cancer of the blood) in the future. Secondary acute leukaemia causes bone marrow (tissue in your bones that produces red and white blood cells) to produce large numbers of cells that do not work properly. Symptoms of this condition include tiredness, fever, infection and bruising. The condition may also be detected by a blood test which will show if there are large numbers of cells in your blood that are not working properly and too few blood cells that are working properly.
Tell your doctor as soon as possible if you have any of these symptoms. You may need to stop taking Alkeran, but only your doctor can tell you if that is the case.
The active ingredient is melphalan. Each Alkeran injection contains 50 mg of melphalan.
The other ingredients are povidone K12 and hydrochloric acid. Alkeran is dissolved in 10ml of solvent before being injected. The solvent contains water for injections, sodium citrate, propylene glycol and ethanol.
This medicinal product contains small amounts of ethanol less than 100mg per dose
It also contains 2mmol (or 46mg) of sodium per vial of reconstituted product, which should be taken into account by patients on a controlled sodium diet
Each pack contains one vial of Alkeran powder and one vial of solvent. The powder vial contains 50mg of the active substance melphalan in a powder format and the solvent vial contains 10ml of a solvent in which to reconstitute (dissolve) the powder.
When a vial of Alkeran powder is reconstituted with 10ml of the solvent, the resultant solution contains 5mg/ml anhydrous melphalan.
Marketing Authorisation holder:
Manufacturer:
This leaflet was last revised in: August 2010
Alkeran is a registered trademark of Aspen. All rights reserved.
10000000090256
Link to this document from your website:http://www.medicines.ie/medicine/9728/XPIL/Alkeran+Injection/